SCHEMBL5773970

SCHEMBL5773970

Clc1nc(C2CC2)[nH]c2cc(-c3ccccc3)nc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.49
ADORA3 P0DMS8 5/20 0.49
ADORA2B P29275 2/20 0.49
ADORA2A P29274 3/20 0.48
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CDC7 O00311 2/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
CCNT1 O60563 1/20 0.38
CDK9 P50750 1/20 0.38
HPGDS O60760 1/20 0.37
POLB P06746 3/20 0.37
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772305 0.86 ADORA3 (0.47) ADORA1ADORA3ADORA2BADORA2AALDH1A1
SCHEMBL5774058 0.86 CSNK1A1 (0.43) MAPT
SCHEMBL5771482 0.81 KDM4E (0.47) ALDH1A1HPGDKDM4EHSD17B10MEN1
SCHEMBL5776767 0.81 KDM4E (0.47) ADORA1ADORA2AALDH1A1HPGDKDM4E
SCHEMBL5774543 0.79 ADORA1 (0.48) ADORA1ADORA3ADORA2AALDH1A1HPGD
SCHEMBL5772105 0.75 KDM4E (0.44) ADORA1ADORA3ADORA2AALDH1A1HPGD
SCHEMBL5773135 0.75 SMN1; SMN2 (0.55) ADORA1ADORA3ADORA2BADORA2AALDH1A1
SCHEMBL5774041 0.75 ADORA3 (0.51) ADORA1ADORA3ADORA2BADORA2AALDH1A1
SCHEMBL5773513 0.73 ADORA3 (0.53) ADORA1ADORA3ADORA2AALDH1A1HPGD
SCHEMBL5776325 0.72 ADORA1 (0.54) ADORA1ADORA3ADORA2BADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed